Healthcare -
Biotechnology - NYSE - US
$ 1.75
-4.37 %
$ 34.1 M
Market Cap
-0.41
P/E
ANVS - OTHER CURRENT LIABILITIES
Other Current Liabilities ANVS - Annovis Bio, Inc.
2.99 M
LAST VALUE
91.02%
2 YEAR CAGR
42.99%
5 YEAR CAGR
0.00%
10 YEAR CAGR